pocketful logo
Colinz Laboratories Ltd logo

Colinz Laboratories Ltd

NSE: BSE: 531210

₹43.47

(4.75%)

Wed, 18 Mar 2026, 03:22 am

Colinz Laboratories Price to Sales Ratio (P/S)

Particulars20082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio30425.8955.5626.7538.712870.4882.8660.9729.2024.4531.2916.7431.7319.2819.4436.75
Price to book ratio0.380.290.520.500.510.321.161.351.401.040.430.600.481.401.081.061.93
Price to sales ratio0.540.420.710.440.420.260.860.981.130.850.390.540.561.541.231.352.80
Price to cash flow ratio14.135.405.129.6519.93371.5013.79121.789.6804.332.1310.0612.029.700
Enterprise value56.47M47.1M57.39M44.01M43.25M25.99M73.2M79.33M77.65M52.24M16.58M18.65M-2.15M60.43M33.61M30.29M133.39M
Enterprise value to EBITDA ratio10.639.8112.218.598.307.5216.1117.5918.9714.574.736.16-0.6510.315.315.5826.83
Debt to equity ratio0.540.530.470.410.380.310.400.270.120.070.100.060.140.060.030.060.07
Return on equity %01.461.221.861.361.121.641.612.343.691.841.912.944.535.785.705.39

Colinz Laboratories Ltd Price to Sales Ratio

The Colinz Laboratories Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Colinz Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Colinz Laboratories Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Colinz Laboratories Ltd (NSE: , BSE: 531210) is currently trading at ₹43.47, with a market capitalization of ₹104.54M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Colinz Laboratories Ltd Price to Sales Ratio is essential for fundamental analysis.

Colinz Laboratories Ltd Price to Sales Ratio Current Value

The current Colinz Laboratories Ltd Price to Sales Ratio stands at 2.80.

The latest Colinz Laboratories Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Colinz Laboratories Ltd Price to Sales Ratio Historical Trend

The Colinz Laboratories Ltd Price to Sales Ratio has shown the following historical trend:

  • 2024: 2.80
  • 2023: 1.35
  • 2022: 1.23
  • 2021: 1.54
  • 2020: 0.56

The recent rise in Colinz Laboratories Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.

What Colinz Laboratories Ltd Price to Sales Ratio Indicates for Investors

The Colinz Laboratories Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Colinz Laboratories Ltd Price to Sales Ratio Analysis Summary

The Colinz Laboratories Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Colinz Laboratories Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Colinz Laboratories Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800